FDA Patient Safety Information Video
A helpful overview explaining the role of MammaPrint as a prognostic test for breast cancer recurrence and the applicability of the test according to the profile of the individual patient.
News- ABCNEWS 2007
ABC NEWS covers a GMA Medical Alert announcing MammaPrint as the first FDA-approved test for breast cancer prognosis. The feature includes observations by the ABCNEWS Medical Editor, Dr. Tim Johnson.
News – NBC 7/39 San Diego 2007
NBC 7/39 Medical Correspondent, Peggy Pico, R.N. introduces MammaPrint as the first, FDA –approved, test for breast cancer prognosis. The presentation includes observations by Steve Gutman from the FDA.
News – NBC’s TODAY program 2007
NBC’s Chief Medical Officer, Dr. Nancy Snyderman introduces MammaPrint as the first, FDA –approved, test for breast cancer prognosis. The presentation includes observations by Dr. Harold J. Burstein, MD, Ph.D. from the Dana Faber Cancer Institute in Boston.
News – NBC’s LifeLine program 2007
An earlier version of NBC’s Chief Medical Officer, Dr. Nancy Snyderman introduction of MammaPrint as the first, FDA –approved, test for breast cancer prognosis. The presentation includes observations by Dr. Harold J. Burstein, MD, Ph.D. from the Dana Faber Cancer Institute in Boston.
MammaPrint Patients Video
This video shows general information about the MammaPrint technology and its advantages for patients.
St. Gallen Oncology Conference 2007
Informative, Complementary, Robust : A breast cancer prognosis test based on gene expression profiling’. Dr. Laura Van’t Veer, a co-founder of Agendia, presents the latest results from MammaPrint.studies at this key event.
MammaPrint Biopsy Instructions
This video shows how to take a tumor sample for the MammaPrint analysis performed by Dr. Hans Hazelberg, Netherlands Cancer Institute (NKI). It also contains general information about MammaPrint and what happens with the tumor sample at Agendia, by Dr. Iris Simon, Agendia BV, Amsterdam
About Agendia